Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
IPSC Century Therapeutics
- 1.220
- -0.030-2.40%
Close Dec 13 16:00 ET
- 1.220
- 0.0000.00%
Post 19:55 ET
103.74MMarket Cap-0.67P/E (TTM)
1.265High1.180Low953.11KVolume1.250Open1.250Pre Close1.16MTurnover2.82%Turnover RatioLossP/E (Static)85.03MShares5.51052wk High0.53P/B41.24MFloat Cap1.14052wk Low--Dividend TTM33.80MShs Float32.899Historical High--Div YieldTTM6.80%Amplitude1.140Historical Low1.218Avg Price1Lot Size
About Century Therapeutics Company
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.
Company Profile
SymbolIPSC
Company NameCentury Therapeutics
Listing DateJun 18, 2021
Issue Price20.00
Founded2018
CEOMr. Brent Pfeiffenberger, M.B.A.,PhD
MarketNASDAQ
Employees165
Fiscal Year Ends12-31
Address38th Street, 25 North,11th Floor
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Phone1-267-817-5790
Websitehttp://www.centurytx.com
Company Executives
- Name
- Position
- Salary
- Brent Pfeiffenberger, M.B.A.,PhD
- Director, President and Chief Executive Officer
- 3.24M
- Dr. Adrienne Farid, PhD
- Chief Operations Officer
- 1.71M
- Dr. Morgan Conn, PhD
- Chief Financial Officer
- --
- Dr. Gregory Russotti, PhD
- Chief Technology and Manufacturing Officer
- 2.59M
- Joseph Jimenez
- Chairman of the Board
- 197.40K
- Dr. Hyam I. Levitsky,M.D.
- President of Research and Development
- --
- Daphne E. Quimi
- Independent Director
- 169.65K
- Dr. Kimberly L. Blackwell, M.D.
- Independent Director
- 165.90K
- Dr. Alessandro Riva, M.D.
- Independent Director
- 161.90K
- Timothy P. Walbert
- Independent Director
- 159.40K
- Dr. Carlo Rizzuto, PhD
- Independent Director
- 168.40K
- Cynthia M. Butitta
- Independent Director
- 170.65K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.